Ruxolitinib is effective in the treatment of a patient with refractory T-ALL.

Jaramillo, Sonia; Hennemann, Hannah; Horak, Peter; Teleanu, Veronica; Heilig, Christoph E; Hutter, Barbara; Stenzinger, Albrecht; Glimm, Hanno; Goeppert, Benjamin; Müller-Tidow, Carsten; Fröhling, Stefan; Schönland, Stefan; Schlenk, Richard F

Jaramillo, Sonia; Hennemann, Hannah; Horak, Peter; Teleanu, Veronica; Heilig, Christoph E; Hutter, Barbara; Stenzinger, Albrecht; Glimm, Hanno; Goeppert, Benjamin; Müller-Tidow, Carsten; Fröhling, Stefan; Schönland, Stefan; Schlenk, Richard F.

Afiliación

Jaramillo S; Department of Hematology Oncology, and Rheumatology Heidelberg University Hospital University of Heidelberg Heidelberg Germany.
Hennemann H; Department of Hematology Oncology, and Rheumatology Heidelberg University Hospital University of Heidelberg Heidelberg Germany.
Horak P; Division of Translational Medical Oncology National Center for Tumor Diseases (NCT) Heidelberg, and German Cancer Research Center (DKFZ) Heidelberg Germany.
Teleanu V; Division of Translational Medical Oncology National Center for Tumor Diseases (NCT) Heidelberg, and German Cancer Research Center (DKFZ) Heidelberg Germany.
Heilig CE; Division of Translational Medical Oncology National Center for Tumor Diseases (NCT) Heidelberg, and German Cancer Research Center (DKFZ) Heidelberg Germany.
Hutter B; Computational Oncology, Molecular Diagnostics Program NCT and DKFZ Heidelberg Germany.
Stenzinger A; Division of Applied Bioinformatics DKFZ Heidelberg Germany.
Glimm H; Institute of Pathology University of Heidelberg Heidelberg Germany.
Goeppert B; German Cancer Consortium (DKTK) Heidelberg Germany.
Müller-Tidow C; Department of Translational Medical Oncology NCT Dresden, Dresden, and DKFZ Heidelberg Germany.
Fröhling S; Center for Personalized Oncology NCT Dresden and University Hospital Carl Gustav Carus Dresden Technical University of Dresden Dresden Germany.
Schönland S; Translational Functional Cancer Genomics NCT and DKFZ Heidelberg Germany.
Schlenk RF; Institute of Pathology University of Heidelberg Heidelberg Germany.

EJHaem ; 2(1): 139-142, 2021 Feb.

Article en En | MEDLINE | ID: mdl-35846099

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: EJHaem Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: EJHaem Año: 2021 Tipo del documento: Article